nodes	percent_of_prediction	percent_of_DWPC	metapath
Isosorbide Mononitrate—GUCY1B3—Nitric oxide stimulates guanylate cyclase—NOS2—esophageal cancer	0.0116	0.0386	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Nitric oxide stimulates guanylate cyclase—NOS2—esophageal cancer	0.0116	0.0386	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Platelet homeostasis—GNG7—esophageal cancer	0.0103	0.0345	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Platelet homeostasis—GNG7—esophageal cancer	0.0103	0.0345	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Nitric oxide stimulates guanylate cyclase—NOS2—esophageal cancer	0.0103	0.0344	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Nitric oxide stimulates guanylate cyclase—NOS3—esophageal cancer	0.00929	0.031	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Nitric oxide stimulates guanylate cyclase—NOS3—esophageal cancer	0.00929	0.031	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Platelet homeostasis—GNG7—esophageal cancer	0.00921	0.0308	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Nitric oxide stimulates guanylate cyclase—NOS3—esophageal cancer	0.00828	0.0277	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Myometrial Relaxation and Contraction Pathways—GSTO1—esophageal cancer	0.00611	0.0204	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—CAPZA1—esophageal cancer	0.00586	0.0196	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—CAPZA1—esophageal cancer	0.00586	0.0196	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Myometrial Relaxation and Contraction Pathways—PDE4D—esophageal cancer	0.00559	0.0187	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—lung—esophageal cancer	0.00541	0.13	CbGeAlD
Isosorbide Mononitrate—GUCY1A3—Myometrial Relaxation and Contraction Pathways—GNG7—esophageal cancer	0.00532	0.0178	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—bronchus—esophageal cancer	0.00528	0.127	CbGeAlD
Isosorbide Mononitrate—GUCY1A3—Myometrial Relaxation and Contraction Pathways—SFN—esophageal cancer	0.00528	0.0176	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—bronchus—esophageal cancer	0.00524	0.126	CbGeAlD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—CAPZA1—esophageal cancer	0.00523	0.0175	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.00488	0.0163	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Myometrial Relaxation and Contraction Pathways—ACTB—esophageal cancer	0.0048	0.016	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—trachea—esophageal cancer	0.00474	0.114	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—trachea—esophageal cancer	0.00471	0.113	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—Platelet homeostasis—NOS2—esophageal cancer	0.0045	0.015	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Platelet homeostasis—NOS2—esophageal cancer	0.0045	0.015	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Platelet homeostasis—NOS2—esophageal cancer	0.00401	0.0134	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—ATP1B2—esophageal cancer	0.00388	0.013	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—ATP1B2—esophageal cancer	0.00388	0.013	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Fatty Acid Omega Oxidation—ADH7—esophageal cancer	0.00386	0.0129	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—lymph node—esophageal cancer	0.0037	0.0888	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—Platelet homeostasis—NOS3—esophageal cancer	0.00362	0.0121	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Platelet homeostasis—NOS3—esophageal cancer	0.00362	0.0121	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—DOCK2—esophageal cancer	0.00351	0.0117	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—DOCK2—esophageal cancer	0.00351	0.0117	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—ATP1B2—esophageal cancer	0.00346	0.0116	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—lung—esophageal cancer	0.00341	0.0817	CbGeAlD
Isosorbide Mononitrate—CYP3A4—Tryptophan metabolism—ALDH3A2—esophageal cancer	0.00339	0.0113	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—esophageal cancer	0.00338	0.0113	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—lung—esophageal cancer	0.00338	0.0811	CbGeAlD
Isosorbide Mononitrate—GUCY1A3—Platelet homeostasis—NOS3—esophageal cancer	0.00322	0.0108	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—DOCK2—esophageal cancer	0.00313	0.0105	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Irinotecan Pathway—ABCC2—esophageal cancer	0.00312	0.0104	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PFN1—esophageal cancer	0.00303	0.0101	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PFN1—esophageal cancer	0.00303	0.0101	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.003	0.01	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—esophageal cancer	0.00286	0.00956	CbGpPWpGaD
Isosorbide Mononitrate—Urine output increased—Capecitabine—esophageal cancer	0.00284	0.0043	CcSEcCtD
Isosorbide Mononitrate—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00282	0.00428	CcSEcCtD
Isosorbide Mononitrate—Hypokalaemia—Cisplatin—esophageal cancer	0.00281	0.00427	CcSEcCtD
Isosorbide Mononitrate—Cramp muscle—Cisplatin—esophageal cancer	0.00278	0.00422	CcSEcCtD
Isosorbide Mononitrate—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00278	0.00422	CcSEcCtD
Isosorbide Mononitrate—Abnormal vision—Capecitabine—esophageal cancer	0.00274	0.00415	CcSEcCtD
Isosorbide Mononitrate—Mental disability—Capecitabine—esophageal cancer	0.00272	0.00413	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PFN1—esophageal cancer	0.0027	0.00903	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.00267	0.00892	CbGpPWpGaD
Isosorbide Mononitrate—Ear pain—Capecitabine—esophageal cancer	0.00267	0.00405	CcSEcCtD
Isosorbide Mononitrate—Sleep disorder—Capecitabine—esophageal cancer	0.00263	0.00399	CcSEcCtD
Isosorbide Mononitrate—Diabetes mellitus—Capecitabine—esophageal cancer	0.00262	0.00397	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal stiffness—Methotrexate—esophageal cancer	0.0026	0.00395	CcSEcCtD
Isosorbide Mononitrate—Sweating increased—Cisplatin—esophageal cancer	0.0026	0.00395	CcSEcCtD
Isosorbide Mononitrate—Polyuria—Capecitabine—esophageal cancer	0.00259	0.00394	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Codeine and Morphine Metabolism—ABCB1—esophageal cancer	0.00259	0.00865	CbGpPWpGaD
Isosorbide Mononitrate—Vascular purpura—Capecitabine—esophageal cancer	0.00255	0.00386	CcSEcCtD
Isosorbide Mononitrate—Glossitis—Methotrexate—esophageal cancer	0.00253	0.00385	CcSEcCtD
Isosorbide Mononitrate—Hyperuricaemia—Methotrexate—esophageal cancer	0.00252	0.00382	CcSEcCtD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—CFL1—esophageal cancer	0.00246	0.00821	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—CFL1—esophageal cancer	0.00246	0.00821	CbGpPWpGaD
Isosorbide Mononitrate—Libido decreased—Capecitabine—esophageal cancer	0.00246	0.00373	CcSEcCtD
Isosorbide Mononitrate—Hot flush—Capecitabine—esophageal cancer	0.00243	0.00369	CcSEcCtD
Isosorbide Mononitrate—Amnesia—Capecitabine—esophageal cancer	0.00242	0.00368	CcSEcCtD
Isosorbide Mononitrate—Increased appetite—Capecitabine—esophageal cancer	0.00242	0.00368	CcSEcCtD
Isosorbide Mononitrate—Menopausal symptoms—Capecitabine—esophageal cancer	0.00241	0.00366	CcSEcCtD
Isosorbide Mononitrate—Atrial fibrillation—Capecitabine—esophageal cancer	0.0024	0.00365	CcSEcCtD
Isosorbide Mononitrate—Thirst—Capecitabine—esophageal cancer	0.00239	0.00363	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—esophageal cancer	0.00238	0.00796	CbGpPWpGaD
Isosorbide Mononitrate—Blood uric acid increased—Methotrexate—esophageal cancer	0.00238	0.00361	CcSEcCtD
Isosorbide Mononitrate—Purpura—Capecitabine—esophageal cancer	0.00236	0.00359	CcSEcCtD
Isosorbide Mononitrate—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00235	0.00356	CcSEcCtD
Isosorbide Mononitrate—Arthritis—Capecitabine—esophageal cancer	0.00234	0.00356	CcSEcCtD
Isosorbide Mononitrate—Myocardial infarction—Cisplatin—esophageal cancer	0.00233	0.00354	CcSEcCtD
Isosorbide Mononitrate—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00233	0.00354	CcSEcCtD
Isosorbide Mononitrate—Cardiac failure—Capecitabine—esophageal cancer	0.00233	0.00354	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—lymph node—esophageal cancer	0.00233	0.0559	CbGeAlD
Isosorbide Mononitrate—Cerebrovascular accident—Capecitabine—esophageal cancer	0.00232	0.00353	CcSEcCtD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—GNG7—esophageal cancer	0.00232	0.00774	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—GNG7—esophageal cancer	0.00232	0.00774	CbGpPWpGaD
Isosorbide Mononitrate—Conjunctivitis—Cisplatin—esophageal cancer	0.00231	0.00351	CcSEcCtD
Isosorbide Mononitrate—GUCY1B3—lymph node—esophageal cancer	0.00231	0.0555	CbGeAlD
Isosorbide Mononitrate—Melaena—Methotrexate—esophageal cancer	0.00228	0.00346	CcSEcCtD
Isosorbide Mononitrate—Diplopia—Capecitabine—esophageal cancer	0.00228	0.00346	CcSEcCtD
Isosorbide Mononitrate—Osteoarthritis—Capecitabine—esophageal cancer	0.00228	0.00346	CcSEcCtD
Isosorbide Mononitrate—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00226	0.00343	CcSEcCtD
Isosorbide Mononitrate—Migraine—Capecitabine—esophageal cancer	0.00224	0.0034	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.00224	0.00749	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—CFL1—esophageal cancer	0.00219	0.00732	CbGpPWpGaD
Isosorbide Mononitrate—Bradycardia—Cisplatin—esophageal cancer	0.00218	0.0033	CcSEcCtD
Isosorbide Mononitrate—Mood swings—Capecitabine—esophageal cancer	0.00216	0.00327	CcSEcCtD
Isosorbide Mononitrate—Urine output increased—Methotrexate—esophageal cancer	0.00211	0.0032	CcSEcCtD
Isosorbide Mononitrate—Urinary tract disorder—Cisplatin—esophageal cancer	0.00211	0.0032	CcSEcCtD
Isosorbide Mononitrate—Urethral disorder—Cisplatin—esophageal cancer	0.00209	0.00318	CcSEcCtD
Isosorbide Mononitrate—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00208	0.00316	CcSEcCtD
Isosorbide Mononitrate—Hypokalaemia—Capecitabine—esophageal cancer	0.00207	0.00314	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—GNG7—esophageal cancer	0.00206	0.0069	CbGpPWpGaD
Isosorbide Mononitrate—Visual impairment—Cisplatin—esophageal cancer	0.00206	0.00313	CcSEcCtD
Isosorbide Mononitrate—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00205	0.00311	CcSEcCtD
Isosorbide Mononitrate—Gastritis—Capecitabine—esophageal cancer	0.00202	0.00306	CcSEcCtD
Isosorbide Mononitrate—Muscular weakness—Capecitabine—esophageal cancer	0.00201	0.00305	CcSEcCtD
Isosorbide Mononitrate—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00201	0.00305	CcSEcCtD
Isosorbide Mononitrate—Tinnitus—Cisplatin—esophageal cancer	0.00199	0.00302	CcSEcCtD
Isosorbide Mononitrate—Flushing—Cisplatin—esophageal cancer	0.00198	0.00301	CcSEcCtD
Isosorbide Mononitrate—Cardiac disorder—Cisplatin—esophageal cancer	0.00198	0.00301	CcSEcCtD
Isosorbide Mononitrate—Asthma—Capecitabine—esophageal cancer	0.00197	0.00299	CcSEcCtD
Isosorbide Mononitrate—Diabetes mellitus—Methotrexate—esophageal cancer	0.00195	0.00296	CcSEcCtD
Isosorbide Mononitrate—Bronchospasm—Capecitabine—esophageal cancer	0.00194	0.00294	CcSEcCtD
Isosorbide Mononitrate—Polyuria—Methotrexate—esophageal cancer	0.00193	0.00293	CcSEcCtD
Isosorbide Mononitrate—Sweating increased—Capecitabine—esophageal cancer	0.00192	0.00291	CcSEcCtD
Isosorbide Mononitrate—Angina pectoris—Capecitabine—esophageal cancer	0.00192	0.00291	CcSEcCtD
Isosorbide Mononitrate—Arrhythmia—Cisplatin—esophageal cancer	0.00191	0.0029	CcSEcCtD
Isosorbide Mononitrate—Bronchitis—Capecitabine—esophageal cancer	0.00189	0.00287	CcSEcCtD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—HSPA5—esophageal cancer	0.00189	0.00631	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—HSPA5—esophageal cancer	0.00189	0.00631	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Xenobiotics—CYP2A6—esophageal cancer	0.00187	0.00626	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Myometrial Relaxation and Contraction Pathways—NOS3—esophageal cancer	0.00186	0.00622	CbGpPWpGaD
Isosorbide Mononitrate—Malnutrition—Cisplatin—esophageal cancer	0.00186	0.00282	CcSEcCtD
Isosorbide Mononitrate—Dysuria—Capecitabine—esophageal cancer	0.00184	0.00279	CcSEcCtD
Isosorbide Mononitrate—Flatulence—Cisplatin—esophageal cancer	0.00183	0.00278	CcSEcCtD
Isosorbide Mononitrate—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00183	0.00278	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.0018	0.00602	CbGpPWpGaD
Isosorbide Mononitrate—Weight increased—Capecitabine—esophageal cancer	0.00179	0.00272	CcSEcCtD
Isosorbide Mononitrate—Muscle spasms—Cisplatin—esophageal cancer	0.00179	0.00271	CcSEcCtD
Isosorbide Mononitrate—Weight decreased—Capecitabine—esophageal cancer	0.00178	0.0027	CcSEcCtD
Isosorbide Mononitrate—Pneumonia—Capecitabine—esophageal cancer	0.00177	0.00268	CcSEcCtD
Isosorbide Mononitrate—Vision blurred—Cisplatin—esophageal cancer	0.00175	0.00266	CcSEcCtD
Isosorbide Mononitrate—Tremor—Cisplatin—esophageal cancer	0.00174	0.00264	CcSEcCtD
Isosorbide Mononitrate—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00173	0.00263	CcSEcCtD
Isosorbide Mononitrate—Cerebrovascular accident—Methotrexate—esophageal cancer	0.00173	0.00263	CcSEcCtD
Isosorbide Mononitrate—Ill-defined disorder—Cisplatin—esophageal cancer	0.00173	0.00262	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.00172	0.00575	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.00172	0.00575	CbGpPWpGaD
Isosorbide Mononitrate—Myocardial infarction—Capecitabine—esophageal cancer	0.00172	0.00261	CcSEcCtD
Isosorbide Mononitrate—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00172	0.00261	CcSEcCtD
Isosorbide Mononitrate—Anaemia—Cisplatin—esophageal cancer	0.00172	0.00261	CcSEcCtD
Isosorbide Mononitrate—Conjunctivitis—Capecitabine—esophageal cancer	0.00171	0.00259	CcSEcCtD
Isosorbide Mononitrate—Urinary tract infection—Capecitabine—esophageal cancer	0.00171	0.00259	CcSEcCtD
Isosorbide Mononitrate—Osteoarthritis—Methotrexate—esophageal cancer	0.0017	0.00257	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—HSPA5—esophageal cancer	0.00168	0.00562	CbGpPWpGaD
Isosorbide Mononitrate—Malaise—Cisplatin—esophageal cancer	0.00168	0.00255	CcSEcCtD
Isosorbide Mononitrate—Haematuria—Capecitabine—esophageal cancer	0.00167	0.00254	CcSEcCtD
Isosorbide Mononitrate—Leukopenia—Cisplatin—esophageal cancer	0.00167	0.00253	CcSEcCtD
Isosorbide Mononitrate—Epistaxis—Capecitabine—esophageal cancer	0.00166	0.00251	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Estrogen metabolism—CYP1B1—esophageal cancer	0.00164	0.00549	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.00161	0.00538	CbGpPWpGaD
Isosorbide Mononitrate—Mood swings—Methotrexate—esophageal cancer	0.00161	0.00244	CcSEcCtD
Isosorbide Mononitrate—Bradycardia—Capecitabine—esophageal cancer	0.0016	0.00243	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Cisplatin—esophageal cancer	0.00158	0.0024	CcSEcCtD
Isosorbide Mononitrate—Haemoglobin—Capecitabine—esophageal cancer	0.00158	0.0024	CcSEcCtD
Isosorbide Mononitrate—Rhinitis—Capecitabine—esophageal cancer	0.00158	0.0024	CcSEcCtD
Isosorbide Mononitrate—Anxiety—Cisplatin—esophageal cancer	0.00158	0.0024	CcSEcCtD
Isosorbide Mononitrate—Haemorrhage—Capecitabine—esophageal cancer	0.00158	0.00239	CcSEcCtD
Isosorbide Mononitrate—Hypoaesthesia—Capecitabine—esophageal cancer	0.00157	0.00238	CcSEcCtD
Isosorbide Mononitrate—Discomfort—Cisplatin—esophageal cancer	0.00156	0.00237	CcSEcCtD
Isosorbide Mononitrate—Pharyngitis—Capecitabine—esophageal cancer	0.00156	0.00237	CcSEcCtD
Isosorbide Mononitrate—Urinary tract disorder—Capecitabine—esophageal cancer	0.00156	0.00236	CcSEcCtD
Isosorbide Mononitrate—Oedema peripheral—Capecitabine—esophageal cancer	0.00155	0.00235	CcSEcCtD
Isosorbide Mononitrate—Urethral disorder—Capecitabine—esophageal cancer	0.00154	0.00234	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.00153	0.00512	CbGpPWpGaD
Isosorbide Mononitrate—Oedema—Cisplatin—esophageal cancer	0.00152	0.0023	CcSEcCtD
Isosorbide Mononitrate—Visual impairment—Capecitabine—esophageal cancer	0.00152	0.0023	CcSEcCtD
Isosorbide Mononitrate—Infection—Cisplatin—esophageal cancer	0.00151	0.00229	CcSEcCtD
Isosorbide Mononitrate—Nervous system disorder—Cisplatin—esophageal cancer	0.00149	0.00226	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Cisplatin—esophageal cancer	0.00149	0.00226	CcSEcCtD
Isosorbide Mononitrate—Tachycardia—Cisplatin—esophageal cancer	0.00148	0.00225	CcSEcCtD
Isosorbide Mononitrate—Skin disorder—Cisplatin—esophageal cancer	0.00147	0.00224	CcSEcCtD
Isosorbide Mononitrate—Tinnitus—Capecitabine—esophageal cancer	0.00147	0.00223	CcSEcCtD
Isosorbide Mononitrate—Hyperhidrosis—Cisplatin—esophageal cancer	0.00147	0.00223	CcSEcCtD
Isosorbide Mononitrate—Asthma—Methotrexate—esophageal cancer	0.00147	0.00222	CcSEcCtD
Isosorbide Mononitrate—Flushing—Capecitabine—esophageal cancer	0.00146	0.00222	CcSEcCtD
Isosorbide Mononitrate—Cardiac disorder—Capecitabine—esophageal cancer	0.00146	0.00222	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.00145	0.00485	CbGpPWpGaD
Isosorbide Mononitrate—Anorexia—Cisplatin—esophageal cancer	0.00145	0.0022	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Cisplatin—esophageal cancer	0.00142	0.00215	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.00142	0.00473	CbGpPWpGaD
Isosorbide Mononitrate—Chills—Capecitabine—esophageal cancer	0.00141	0.00214	CcSEcCtD
Isosorbide Mononitrate—Arrhythmia—Capecitabine—esophageal cancer	0.00141	0.00214	CcSEcCtD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—ABL1—esophageal cancer	0.0014	0.00467	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—ABL1—esophageal cancer	0.0014	0.00467	CbGpPWpGaD
Isosorbide Mononitrate—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00138	0.0021	CcSEcCtD
Isosorbide Mononitrate—Mental disorder—Capecitabine—esophageal cancer	0.00138	0.00209	CcSEcCtD
Isosorbide Mononitrate—Malnutrition—Capecitabine—esophageal cancer	0.00137	0.00208	CcSEcCtD
Isosorbide Mononitrate—Dysuria—Methotrexate—esophageal cancer	0.00137	0.00208	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Cisplatin—esophageal cancer	0.00136	0.00207	CcSEcCtD
Isosorbide Mononitrate—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00136	0.00207	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Cisplatin—esophageal cancer	0.00135	0.00205	CcSEcCtD
Isosorbide Mononitrate—Flatulence—Capecitabine—esophageal cancer	0.00135	0.00205	CcSEcCtD
Isosorbide Mononitrate—Erectile dysfunction—Methotrexate—esophageal cancer	0.00135	0.00205	CcSEcCtD
Isosorbide Mononitrate—Dysgeusia—Capecitabine—esophageal cancer	0.00134	0.00204	CcSEcCtD
Isosorbide Mononitrate—Back pain—Capecitabine—esophageal cancer	0.00133	0.00201	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Cisplatin—esophageal cancer	0.00132	0.002	CcSEcCtD
Isosorbide Mononitrate—Muscle spasms—Capecitabine—esophageal cancer	0.00132	0.002	CcSEcCtD
Isosorbide Mononitrate—Pneumonia—Methotrexate—esophageal cancer	0.00131	0.00199	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00131	0.00199	CcSEcCtD
Isosorbide Mononitrate—Pain—Cisplatin—esophageal cancer	0.0013	0.00197	CcSEcCtD
Isosorbide Mononitrate—Vision blurred—Capecitabine—esophageal cancer	0.00129	0.00196	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.00129	0.0043	CbGpPWpGaD
Isosorbide Mononitrate—Tremor—Capecitabine—esophageal cancer	0.00128	0.00195	CcSEcCtD
Isosorbide Mononitrate—Ill-defined disorder—Capecitabine—esophageal cancer	0.00127	0.00193	CcSEcCtD
Isosorbide Mononitrate—Conjunctivitis—Methotrexate—esophageal cancer	0.00127	0.00193	CcSEcCtD
Isosorbide Mononitrate—Anaemia—Capecitabine—esophageal cancer	0.00127	0.00192	CcSEcCtD
Isosorbide Mononitrate—Sweating—Methotrexate—esophageal cancer	0.00125	0.0019	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Cisplatin—esophageal cancer	0.00125	0.0019	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—ABL1—esophageal cancer	0.00125	0.00416	CbGpPWpGaD
Isosorbide Mononitrate—Haematuria—Methotrexate—esophageal cancer	0.00125	0.00189	CcSEcCtD
Isosorbide Mononitrate—Malaise—Capecitabine—esophageal cancer	0.00124	0.00188	CcSEcCtD
Isosorbide Mononitrate—Epistaxis—Methotrexate—esophageal cancer	0.00123	0.00187	CcSEcCtD
Isosorbide Mononitrate—Vertigo—Capecitabine—esophageal cancer	0.00123	0.00187	CcSEcCtD
Isosorbide Mononitrate—Syncope—Capecitabine—esophageal cancer	0.00123	0.00187	CcSEcCtD
Isosorbide Mononitrate—Leukopenia—Capecitabine—esophageal cancer	0.00123	0.00186	CcSEcCtD
Isosorbide Mononitrate—Palpitations—Capecitabine—esophageal cancer	0.00121	0.00184	CcSEcCtD
Isosorbide Mononitrate—Loss of consciousness—Capecitabine—esophageal cancer	0.00121	0.00183	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Cisplatin—esophageal cancer	0.0012	0.00182	CcSEcCtD
Isosorbide Mononitrate—Cough—Capecitabine—esophageal cancer	0.0012	0.00182	CcSEcCtD
Isosorbide Mononitrate—Hypertension—Capecitabine—esophageal cancer	0.00118	0.0018	CcSEcCtD
Isosorbide Mononitrate—Haemoglobin—Methotrexate—esophageal cancer	0.00118	0.00179	CcSEcCtD
Isosorbide Mononitrate—Haemorrhage—Methotrexate—esophageal cancer	0.00117	0.00178	CcSEcCtD
Isosorbide Mononitrate—Arthralgia—Capecitabine—esophageal cancer	0.00117	0.00177	CcSEcCtD
Isosorbide Mononitrate—Chest pain—Capecitabine—esophageal cancer	0.00117	0.00177	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Capecitabine—esophageal cancer	0.00117	0.00177	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—digestive system—esophageal cancer	0.00116	0.028	CbGeAlD
Isosorbide Mononitrate—Pharyngitis—Methotrexate—esophageal cancer	0.00116	0.00177	CcSEcCtD
Isosorbide Mononitrate—Anxiety—Capecitabine—esophageal cancer	0.00116	0.00177	CcSEcCtD
Isosorbide Mononitrate—Urinary tract disorder—Methotrexate—esophageal cancer	0.00116	0.00176	CcSEcCtD
Isosorbide Mononitrate—Discomfort—Capecitabine—esophageal cancer	0.00115	0.00175	CcSEcCtD
Isosorbide Mononitrate—Urethral disorder—Methotrexate—esophageal cancer	0.00115	0.00174	CcSEcCtD
Isosorbide Mononitrate—Dry mouth—Capecitabine—esophageal cancer	0.00114	0.00173	CcSEcCtD
Isosorbide Mononitrate—Visual impairment—Methotrexate—esophageal cancer	0.00113	0.00171	CcSEcCtD
Isosorbide Mononitrate—Confusional state—Capecitabine—esophageal cancer	0.00113	0.00171	CcSEcCtD
Isosorbide Mononitrate—Oedema—Capecitabine—esophageal cancer	0.00112	0.0017	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Cisplatin—esophageal cancer	0.00112	0.0017	CcSEcCtD
Isosorbide Mononitrate—Infection—Capecitabine—esophageal cancer	0.00111	0.00169	CcSEcCtD
Isosorbide Mononitrate—Shock—Capecitabine—esophageal cancer	0.0011	0.00167	CcSEcCtD
Isosorbide Mononitrate—Nervous system disorder—Capecitabine—esophageal cancer	0.0011	0.00167	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Capecitabine—esophageal cancer	0.0011	0.00166	CcSEcCtD
Isosorbide Mononitrate—Tinnitus—Methotrexate—esophageal cancer	0.00109	0.00166	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00109	0.00365	CbGpPWpGaD
Isosorbide Mononitrate—Tachycardia—Capecitabine—esophageal cancer	0.00109	0.00166	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Cisplatin—esophageal cancer	0.00109	0.00165	CcSEcCtD
Isosorbide Mononitrate—Cardiac disorder—Methotrexate—esophageal cancer	0.00109	0.00165	CcSEcCtD
Isosorbide Mononitrate—Skin disorder—Capecitabine—esophageal cancer	0.00109	0.00165	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00109	0.00363	CbGpPWpGaD
Isosorbide Mononitrate—Hyperhidrosis—Capecitabine—esophageal cancer	0.00108	0.00164	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00108	0.0036	CbGpPWpGaD
Isosorbide Mononitrate—Anorexia—Capecitabine—esophageal cancer	0.00107	0.00162	CcSEcCtD
Isosorbide Mononitrate—Chills—Methotrexate—esophageal cancer	0.00105	0.0016	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Capecitabine—esophageal cancer	0.00105	0.00159	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Cisplatin—esophageal cancer	0.00104	0.00158	CcSEcCtD
Isosorbide Mononitrate—Mental disorder—Methotrexate—esophageal cancer	0.00103	0.00156	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.00102	0.00342	CbGpPWpGaD
Isosorbide Mononitrate—Malnutrition—Methotrexate—esophageal cancer	0.00102	0.00155	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00102	0.00155	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Capecitabine—esophageal cancer	0.00101	0.00154	CcSEcCtD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—NOS2—esophageal cancer	0.00101	0.00337	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—NOS2—esophageal cancer	0.00101	0.00337	CbGpPWpGaD
Isosorbide Mononitrate—Paraesthesia—Capecitabine—esophageal cancer	0.00101	0.00153	CcSEcCtD
Isosorbide Mononitrate—Dysgeusia—Methotrexate—esophageal cancer	0.001	0.00152	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Capecitabine—esophageal cancer	0.000998	0.00151	CcSEcCtD
Isosorbide Mononitrate—Back pain—Methotrexate—esophageal cancer	0.000988	0.0015	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Capecitabine—esophageal cancer	0.000985	0.0015	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Capecitabine—esophageal cancer	0.000973	0.00148	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000966	0.00147	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Cisplatin—esophageal cancer	0.000965	0.00146	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Capecitabine—esophageal cancer	0.000965	0.00146	CcSEcCtD
Isosorbide Mononitrate—Vision blurred—Methotrexate—esophageal cancer	0.000962	0.00146	CcSEcCtD
Isosorbide Mononitrate—Rash—Cisplatin—esophageal cancer	0.000957	0.00145	CcSEcCtD
Isosorbide Mononitrate—Pain—Capecitabine—esophageal cancer	0.000957	0.00145	CcSEcCtD
Isosorbide Mononitrate—Constipation—Capecitabine—esophageal cancer	0.000957	0.00145	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Cisplatin—esophageal cancer	0.000956	0.00145	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.000953	0.00318	CbGpPWpGaD
Isosorbide Mononitrate—Ill-defined disorder—Methotrexate—esophageal cancer	0.000947	0.00144	CcSEcCtD
Isosorbide Mononitrate—Anaemia—Methotrexate—esophageal cancer	0.000944	0.00143	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Capecitabine—esophageal cancer	0.000922	0.0014	CcSEcCtD
Isosorbide Mononitrate—Malaise—Methotrexate—esophageal cancer	0.000921	0.0014	CcSEcCtD
Isosorbide Mononitrate—Vertigo—Methotrexate—esophageal cancer	0.000917	0.00139	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000915	0.00139	CcSEcCtD
Isosorbide Mononitrate—Leukopenia—Methotrexate—esophageal cancer	0.000914	0.00139	CcSEcCtD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—CREBBP—esophageal cancer	0.000905	0.00302	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—CREBBP—esophageal cancer	0.000905	0.00302	CbGpPWpGaD
Isosorbide Mononitrate—Nausea—Cisplatin—esophageal cancer	0.000902	0.00137	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—NOS2—esophageal cancer	0.000898	0.003	CbGpPWpGaD
Isosorbide Mononitrate—Cough—Methotrexate—esophageal cancer	0.000891	0.00135	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000886	0.00296	CbGpPWpGaD
Isosorbide Mononitrate—Abdominal pain—Capecitabine—esophageal cancer	0.000885	0.00134	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Capecitabine—esophageal cancer	0.000885	0.00134	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Methotrexate—esophageal cancer	0.000869	0.00132	CcSEcCtD
Isosorbide Mononitrate—Chest pain—Methotrexate—esophageal cancer	0.000869	0.00132	CcSEcCtD
Isosorbide Mononitrate—Arthralgia—Methotrexate—esophageal cancer	0.000869	0.00132	CcSEcCtD
Isosorbide Mononitrate—Discomfort—Methotrexate—esophageal cancer	0.000859	0.0013	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.000854	0.00285	CbGpPWpGaD
Isosorbide Mononitrate—Confusional state—Methotrexate—esophageal cancer	0.00084	0.00127	CcSEcCtD
Isosorbide Mononitrate—Infection—Methotrexate—esophageal cancer	0.000828	0.00126	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Capecitabine—esophageal cancer	0.000825	0.00125	CcSEcCtD
Isosorbide Mononitrate—Nervous system disorder—Methotrexate—esophageal cancer	0.000817	0.00124	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Methotrexate—esophageal cancer	0.000816	0.00124	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000814	0.00272	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—NOS3—esophageal cancer	0.00081	0.00271	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—NOS3—esophageal cancer	0.00081	0.00271	CbGpPWpGaD
Isosorbide Mononitrate—Skin disorder—Methotrexate—esophageal cancer	0.000809	0.00123	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—CREBBP—esophageal cancer	0.000807	0.0027	CbGpPWpGaD
Isosorbide Mononitrate—Hyperhidrosis—Methotrexate—esophageal cancer	0.000805	0.00122	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Capecitabine—esophageal cancer	0.000803	0.00122	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Methotrexate—esophageal cancer	0.000794	0.00121	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Capecitabine—esophageal cancer	0.000792	0.0012	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Methotrexate—esophageal cancer	0.000779	0.00118	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000778	0.0026	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000776	0.00259	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000768	0.00257	CbGpPWpGaD
Isosorbide Mononitrate—Diarrhoea—Capecitabine—esophageal cancer	0.000766	0.00116	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000759	0.00115	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Methotrexate—esophageal cancer	0.000754	0.00114	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Methotrexate—esophageal cancer	0.000748	0.00114	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Methotrexate—esophageal cancer	0.000743	0.00113	CcSEcCtD
Isosorbide Mononitrate—Somnolence—Methotrexate—esophageal cancer	0.000741	0.00112	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Capecitabine—esophageal cancer	0.00074	0.00112	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Methotrexate—esophageal cancer	0.000733	0.00111	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.00073	0.00244	CbGpPWpGaD
Isosorbide Mononitrate—Decreased appetite—Methotrexate—esophageal cancer	0.000724	0.0011	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—NOS3—esophageal cancer	0.000722	0.00241	CbGpPWpGaD
Isosorbide Mononitrate—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000719	0.00109	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Methotrexate—esophageal cancer	0.000718	0.00109	CcSEcCtD
Isosorbide Mononitrate—Pain—Methotrexate—esophageal cancer	0.000713	0.00108	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Capecitabine—esophageal cancer	0.000712	0.00108	CcSEcCtD
Isosorbide Mononitrate—Rash—Capecitabine—esophageal cancer	0.000706	0.00107	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Capecitabine—esophageal cancer	0.000705	0.00107	CcSEcCtD
Isosorbide Mononitrate—Headache—Capecitabine—esophageal cancer	0.000701	0.00106	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Methotrexate—esophageal cancer	0.000687	0.00104	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000681	0.00103	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000671	0.00224	CbGpPWpGaD
Isosorbide Mononitrate—Nausea—Capecitabine—esophageal cancer	0.000665	0.00101	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Methotrexate—esophageal cancer	0.000659	0.000999	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Methotrexate—esophageal cancer	0.000659	0.000999	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000631	0.00211	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000627	0.0021	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000619	0.00207	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—EP300—esophageal cancer	0.000616	0.00206	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—EP300—esophageal cancer	0.000616	0.00206	CbGpPWpGaD
Isosorbide Mononitrate—Hypersensitivity—Methotrexate—esophageal cancer	0.000614	0.000932	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000598	0.002	CbGpPWpGaD
Isosorbide Mononitrate—Asthenia—Methotrexate—esophageal cancer	0.000598	0.000907	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00059	0.00197	CbGpPWpGaD
Isosorbide Mononitrate—Pruritus—Methotrexate—esophageal cancer	0.000589	0.000895	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000582	0.00194	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000577	0.00193	CbGpPWpGaD
Isosorbide Mononitrate—Diarrhoea—Methotrexate—esophageal cancer	0.00057	0.000865	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Methotrexate—esophageal cancer	0.000551	0.000836	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—EP300—esophageal cancer	0.000549	0.00184	CbGpPWpGaD
Isosorbide Mononitrate—Vomiting—Methotrexate—esophageal cancer	0.00053	0.000804	CcSEcCtD
Isosorbide Mononitrate—Rash—Methotrexate—esophageal cancer	0.000525	0.000797	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Methotrexate—esophageal cancer	0.000525	0.000796	CcSEcCtD
Isosorbide Mononitrate—Headache—Methotrexate—esophageal cancer	0.000522	0.000792	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000509	0.0017	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000506	0.00169	CbGpPWpGaD
Isosorbide Mononitrate—Nausea—Methotrexate—esophageal cancer	0.000495	0.000751	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000478	0.0016	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.00047	0.00157	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000464	0.00155	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PIK3CA—esophageal cancer	0.000456	0.00152	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PIK3CA—esophageal cancer	0.000456	0.00152	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—TP53—esophageal cancer	0.000441	0.00147	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—TP53—esophageal cancer	0.000441	0.00147	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000437	0.00146	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000431	0.00144	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PIK3CA—esophageal cancer	0.000406	0.00136	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—TP53—esophageal cancer	0.000393	0.00131	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000357	0.00119	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000339	0.00113	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000335	0.00112	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000318	0.00106	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.00027	0.000903	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000266	0.00089	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000254	0.000849	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000251	0.000837	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000136	0.000456	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000136	0.000456	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CA1—esophageal cancer	0.000116	0.000388	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000116	0.000388	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CA2—esophageal cancer	0.000106	0.000355	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ADH7—esophageal cancer	9.87e-05	0.00033	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PLCE1—esophageal cancer	9.87e-05	0.00033	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ADH1B—esophageal cancer	8.65e-05	0.000289	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—TYMP—esophageal cancer	8.27e-05	0.000276	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CYP26A1—esophageal cancer	8.04e-05	0.000269	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ALOX15—esophageal cancer	7.84e-05	0.000262	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GSTO1—esophageal cancer	7.48e-05	0.00025	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—TPI1—esophageal cancer	7.48e-05	0.00025	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ALDOB—esophageal cancer	7.17e-05	0.00024	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GAPDH—esophageal cancer	6.9e-05	0.000231	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CRABP1—esophageal cancer	6.84e-05	0.000229	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GNG7—esophageal cancer	6.51e-05	0.000217	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ALDH2—esophageal cancer	6.1e-05	0.000204	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.8e-05	0.000194	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CYP2A6—esophageal cancer	5.73e-05	0.000192	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ENO1—esophageal cancer	5.43e-05	0.000182	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PTGS1—esophageal cancer	5.43e-05	0.000182	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PSME2—esophageal cancer	5.35e-05	0.000179	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PSME1—esophageal cancer	5.35e-05	0.000179	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.62e-05	0.000154	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CYP19A1—esophageal cancer	4.34e-05	0.000145	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.96e-05	0.000132	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.8e-05	0.000127	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.54e-05	8.5e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—NOS3—esophageal cancer	2.28e-05	7.61e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.08e-05	6.96e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—EP300—esophageal cancer	1.73e-05	5.79e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.28e-05	4.28e-05	CbGpPWpGaD
